Category: Life Sciences
New Zealand Life Sciences
-
2024 New Zealand Genetic Diseases, Cancer, Forensic, Paternity Molecular Diagnostics Market Opportunities - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Market Barrier
... report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products for diagnosing genetic diseases, cancer, as well as forensic and paternity/HLA testing during ... Read More
-
2024 New Zealand Molecular Diagnostics Market: 2023 Supplier Shares, Instrumentation Installed Base and Strategies, 2023-2028 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
... 2023 supplier shares, the 2023-2028 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or marketing new technologies and products ... Read More
-
Adult Bovine Serum Market by Origin (Australia-Sourced, New Zealand-Sourced, North America-Sourced), Application (Bioprocessing, Cell Culture, Vaccine Production), End-User - Global Forecast 2024-2030
... 2023 and expected to reach USD 148.18 million in 2024, at a CAGR 5.61% to reach USD 205.99 million by 2030. Adult bovine serum (ABS) is an animal-derived serum extracted from the blood of adult ... Read More
-
Australia & New Zealand Cbd Food & Beverage Market Forecast 2024-2032
... base year considered for the studied market is 2023, and the forecasted years are from 2024 to 2032. MARKET INSIGHTS The production of cannabis edibles in Australia involves the incorporation of THC and CBD ingredients. ... Read More
-
2024 New Zealand Virology, Bacteriology, Parasitology and Mycology Market Database: 2023 Supplier Shares, 2023-2028 Volume and Sales Segment Forecasts for 100 Respiratory, STD, Gastrointestinal and Other Microbiology Tests
... supplier shares, the 2023-2028 volume and sales forecasts for 100 major infectious disease tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including: AIDS/HIV, Adenovirus, Aeromonads, Bartonella, ... Read More
-
2024 Database: New Zealand Automated Microbiology Database: 2023 Supplier Shares and 2023-2028 Segment Forecasts for over 100 Molecular, Identification, Susceptibility, Culture, Urine Screening and Immunodiagnostic Tests
... the 2023-2028 volume and sales forecasts for over 100 tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including: AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, ... Read More
-
2024 New Zealand Coagulation Market Database - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 40 Hemostasis Tests
... other published source . This database from LeadingMarketResearch.com provides the 2023 supplier shares, the 2023-2028 volume and sales forecasts for major coagulation tests, as well as comprehensive lists of companies developing or marketing new technologies ... Read More
-
2024 New Zealand Immunodiagnostics Market Database - 2023 Supplier Shares, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer, Clinical Chemistry, Endocrine, Immunoprotein and TDM Tests
... and analysis not available from any other published source . This database from LeadingMarketResearch.com provides the 2023 supplier shares, the 2023-2028 volume and sales forecasts for 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused ... Read More
-
2024 New Zealand Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Instrumentation Pipeline, Emerging Opportunities for Suppliers This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging ... Read More
-
Veterinary Pharmaceutical and Medicinal Product Manufacturing in New Zealand - Industry Market Research Report
... in dairy cattle, sheep and deer numbers are reducing demand for veterinary pharmaceuticals. Meanwhile, rising beef cattle herd sizes and increased spending on pet health care are driving sales. Concerns over antibiotic resistance are disrupting ... Read More
-
Hospitals in New Zealand - Industry Market Research Report
... public hospitals requiring additional support and assistance through the COVID-19 pandemic. In contrast, private hospitals have faced reduced demand for elective surgeries as a result of the pandemic, weakening growth in the private sector. Overall, ... Read More
-
Australia & New Zealand Cannabis Testing Market Forecast 2024-2032
... promote market growth, such as recognition of cannabis for medical and therapeutic use by the medical fraternity, rise in the number of testing facilities, increasing legalization of the use of cannabis for medicine and research, ... Read More
-
2024 New Zealand Hematology and Flow Cytometry Database: Analyzers and Reagents, Supplier Shares, Test Volume and Sales Forecasts
... hematology and flow cytometry tests, including: Hematology Tests CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils Flow ... Read More
-
2024 New Zealand Infectious Disease Testing Market Shares-Competitive Analysis of Leading and Emerging Market Players
... analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in the report include: Abbott Agilent Technologies Applied Gene Technologies Arca ... Read More
-
Asia Pacific Lancet and Pen Needles Market, By Length (4mm, 5mm, 6mm, 8mm, Others); By Gauge (17/18G, 21G, 23G, Others); By Application (Blood Glucose Monitoring, Insulin Delivery, Others); By Mode of Purchase (Retail, Non-retail); By End User (Clinics, Hospitals, Medical Institutions, Others); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... End User (Clinics, Hospitals, Medical Institutions, Others); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Trend Analysis, Competitive Landscape & Forecast, 2019–2030 Asia Pacific Lancet ... Read More
-
2024 New Zealand Hemostasis Analyzers and Reagents - Chromogenic, Immunodiagnostic, Molecular Coagulation Test Volume and Sales Segment Forecasts - 2023 Competitive Shares and Growth Strategies, Latest Technologies and Instrumentation Pipeline, Emerging O
... This comprehensive report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities during the next five years The report explores market and technological trends; provides reagent, ... Read More
-
Asia-Pacific Omega-3 Supplements Market, By Source (Fish Oil, Krill Oil, Algae Oil, Others), By Form (Tablets, Capsules, Soft Gels, Others), By Functionality (Cardiovascular Health, Brain, Nervous System & Mental Health, Eye Diseases, Diabetes, Others), By End User (Adults, Geriatric, Pregnant Women, Children, Infants), By Distribution Channel (Supermarkets/ Hypermarkets/Food Stores, Drug Stores & Pharmacies, Online Retailers, Others), By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... End User (Adults, Geriatric, Pregnant Women, Children, Infants), By Distribution Channel (Supermarkets/ Hypermarkets/Food Stores, Drug Stores & Pharmacies, Online Retailers, Others), By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, ... Read More
-
New Zealand Continuous Glucose Monitoring Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... 2024, and is expected to reach NZD 96.32 million by 2029, growing at a CAGR of 13.60% during the forecast period (2024-2029). The COVID-19 pandemic highlighted that substantially greater attention had to be given to ... Read More
-
New Zealand Self-Monitoring Blood Glucose - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... is expected to reach USD 196.72 million by 2029, growing at a CAGR of 5.20% during the forecast period (2024-2029). The COVID-19 pandemic showed that diabetes needs a lot more attention if we don't want ... Read More
-
Australia And New Zealand Diabetes Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... 2024, and is expected to reach USD 1.30 billion by 2029, growing at a CAGR of 2.70% during the forecast period (2024-2029). Key Highlights A holistic study of the market studied has been carried out ... Read More
-
New Zealand Insulin Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... 2024, and is expected to reach USD 552.60 million by 2029, growing at a CAGR of 1.10% during the forecast period (2024-2029). After COVID-19 was detected, the risk of developing type 1 diabetes increased. The ... Read More
-
New Zealand Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... is expected to reach USD 367.23 million by 2029, growing at a CAGR of 2.60% during the forecast period (2024-2029). The likelihood of having type 1 diabetes increased when COVID-19 was discovered. Young pediatric patients ... Read More
-
New Zealand Diabetes Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... to reach USD 872.63 million by 2029, growing at a CAGR of 4% during the forecast period (2024-2029). Type 1 diabetes was more likely to occur after being diagnosed with COVID-19. Young pediatric patients and ... Read More
-
New Zealand Diabetes Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... to reach USD 512.09 million by 2029, growing at a CAGR of 3.30% during the forecast period (2024-2029). An individual's risk of infection, including other viral infections like the flu, is increased by diabetes. If ... Read More
-
Personal Welfare Services in New Zealand - Industry Market Research Report
... the system's viability was questioned on economic grounds. In the following decades, a new emphasis on community care and deinstitutionalisation led to the community and voluntary social service sector assuming a greater role in providing ... Read More
Research Assistance
